Rankings
▼
Calendar
BHVN Q3 2019 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena
BHVN
Biohaven Ltd.
$1B
Q3 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$90M
Net Income
-$106M
EPS (Diluted)
$-2.04
QoQ Revenue Growth
NaN%
Balance Sheet
Total Assets
$439M
Total Liabilities
$320M
Stockholders' Equity
$119M
Cash & Equivalents
$417M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$90M
-$55M
-64.7%
Net Income
-$106M
-$61M
-72.8%
← FY 2019
All Quarters
Q4 2019 →